Cargando…

Application of non‐invasive bioreactance to assess hemodynamic function in patients with hypertrophic cardiomyopathy

Non‐invasive technologies have become popular for the clinical evaluation of cardiac function. The present study evaluated hemodynamic response to cardiopulmonary exercise stress testing using bioreactance technology in patients with hypertrophic cardiomyopathy. The study included 29 patients with H...

Descripción completa

Detalles Bibliográficos
Autores principales:	Okwose, Nduka Charles, Fuller, Amy S., Alyahya, Alaa I., Charman, Sarah J., Eggett, Christopher, Luke, Peter, MacGowan, Guy A., Jakovljevic, Djordje G.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2023
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10277211/ https://www.ncbi.nlm.nih.gov/pubmed/37332077 http://dx.doi.org/10.14814/phy2.15729

Ejemplares similares

Genetic determinants of clinical phenotype in hypertrophic cardiomyopathy
por: Velicki, Lazar, et al.
Publicado: (2020)

Gender Related Differences in the Clinical Presentation of Hypertrophic Cardiomyopathy—An Analysis from the SILICOFCM Database
por: Preveden, Andrej, et al.
Publicado: (2022)

Overcoming barriers to engagement and adherence to a home-based physical activity intervention for patients with heart failure: a qualitative focus group study
por: Okwose, Nduka C, et al.
Publicado: (2020)

Insights into heart failure hospitalizations, management, and services during and beyond COVID‐19
por: Charman, Sarah J., et al.
Publicado: (2020)

NT‐proBNP is a weak indicator of cardiac function and haemodynamic response to exercise in chronic heart failure
por: Parovic, Milos, et al.
Publicado: (2019)

High intensity interval training protects the heart during increased metabolic demand in patients with type 2 diabetes: a randomised controlled trial
por: Suryanegara, Jose, et al.
Publicado: (2018)

Acceptability, Feasibility and Preliminary Evaluation of a Novel, Personalised, Home-Based Physical Activity Intervention for Chronic Heart Failure (Active-at-Home-HF): a Pilot Study
por: Okwose, Nduka C., et al.
Publicado: (2019)

Haemodynamic determinants of quality of life in chronic heart failure
por: Fatrin, Serlie, et al.
Publicado: (2022)

Opportunities and challenges of a novel cardiac output response to stress (CORS) test to enhance diagnosis of heart failure in primary care: qualitative study
por: Charman, Sarah, et al.
Publicado: (2019)

Feasibility of the cardiac output response to stress test in suspected heart failure patients
por: Charman, Sarah J, et al.
Publicado: (2022)

Disease Progression of Hypertrophic Cardiomyopathy: Modeling Using Machine Learning
por: Pičulin, Matej, et al.
Publicado: (2022)

A novel cardiac output response to stress test developed to improve diagnosis and monitoring of heart failure in primary care
por: Charman, Sarah J., et al.
Publicado: (2018)

Design of the SILICOFCM study: Effect of sacubitril/valsartan vs lifestyle intervention on functional capacity in patients with hypertrophic cardiomyopathy
por: Tafelmeier, Maria, et al.
Publicado: (2020)

Age-related decline in cardiac autonomic function is not attenuated with increased physical activity
por: Njemanze, Hugo, et al.
Publicado: (2016)

Bioreaction engineering principles /
por: Villadsen, John
Publicado: (2011)

A systematic review of rehabilitation in chronic heart failure: evaluating the reporting of exercise interventions
por: Harwood, Amy E., et al.
Publicado: (2021)

Disruption of embryonic ROCK signaling reproduces the sarcomeric phenotype of hypertrophic cardiomyopathy
por: Bailey, Kate E., et al.
Publicado: (2019)

Disruption of embryonic ROCK signaling reproduces the sarcomeric phenotype of hypertrophic cardiomyopathy
por: Bailey, Kate E., et al.
Publicado: (2020)

Hemodynamic Assessment of Pregnant People with and without Obesity by Noninvasive Bioreactance: A Pilot Study
por: Figueiro-Filho, Ernesto A., et al.
Publicado: (2022)

The Role of Cardiopulmonary Exercise Testing in Hypertrophic Cardiomyopathy
por: Mikic, Lidija, et al.
Publicado: (2023)

Impact of age on the association between cardiac high-energy phosphate metabolism and cardiac power in women
por: Nathania, Maria, et al.
Publicado: (2018)

Concentric hypertrophic remodelling and subendocardial dysfunction in mitochondrial DNA point mutation carriers(†)
por: Bates, Matthew G.D., et al.
Publicado: (2013)

Hemodynamic response to supraventricular tachycardia in a patient with hypertrophic cardiomyopathy
por: Ebrille, Elisa, et al.
Publicado: (2018)

Assessing the feasibility and acceptability of Changing Health for the management of prediabetes: protocol for a pilot study of a digital behavioural intervention
por: Cassidy, Sophie, et al.
Publicado: (2019)

Apical hypertrophic cardiomyopathy with hemodynamically unstable ventricular arrhythmia – Atypical presentation
por: Chaturvedi, Hemant, et al.
Publicado: (2016)

Image-Based Computational Hemodynamics Analysis of Systolic Obstruction in Hypertrophic Cardiomyopathy
por: Fumagalli, Ivan, et al.
Publicado: (2022)

The effect of age on the relationship between cardiac and vascular function
por: Houghton, David, et al.
Publicado: (2016)

Controls on Dissolved Organic Carbon Bioreactivity in River Systems
por: Soares, Ana R. A., et al.
Publicado: (2019)

AAV process intensification by perfusion bioreaction and integrated clarification
por: Mendes, João P., et al.
Publicado: (2022)

Validity and reliability of short‐term heart‐rate variability from disposable electrocardiography leads
por: Okwose, Nduka C., et al.
Publicado: (2022)

Subtypes and Mechanisms of Hypertrophic Cardiomyopathy Proposed by Machine Learning Algorithms
por: Glavaški, Mila, et al.
Publicado: (2022)

Hemodynamic Consequences of Hypertrophic Cardiomyopathy with Midventricular Obstruction: Apical Aneurysm and Thrombus Formation
por: Saba, Shahryar G, et al.
Publicado: (2014)

Hemodynamic Predictors of Outcome Following Alcohol Septal Ablation for Hypertrophic Obstructive Cardiomyopathy
por: Alabdaljabar, Mohamad S., et al.
Publicado: (2023)

Beta-Blockers, Left and Right Ventricular Function, and In-Vivo Calcium Influx in Muscular Dystrophy Cardiomyopathy
por: Blain, Alison, et al.
Publicado: (2013)

Evaluation of hemodynamics in patients with hypertrophic cardiomyopathy by vector flow mapping: Comparison with healthy subjects
por: Cao, Yuan, et al.
Publicado: (2019)

Hypertrophic cardiomyopathy
por: Antunes, Murillo de Oliveira, et al.
Publicado: (2020)

Hypertrophic Cardiomyopathy
por: Butt, Asra K., et al.
Publicado: (2023)

Unsupervised high-intensity interval training improves glycaemic control but not cardiovascular autonomic function in type 2 diabetes patients: A randomised controlled trial
por: Cassidy, Sophie, et al.
Publicado: (2018)

Pathophysiology of exercise intolerance in chronic diseases: the role of diminished cardiac performance in mitochondrial and heart failure patients
por: McCoy, Jodi, et al.
Publicado: (2017)

Bioreactance versus PICCOTD/PC in critically ill septic shock patients
por: Monti, G, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_pq8i2u2omlmv0ucp99s8lje9i8